Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

The significance of the US Food and Drug Administration for dental professionals and safe patient care.

Collins FM.

J Am Dent Assoc. 2017 Nov;148(11):858-861. doi: 10.1016/j.adaj.2017.08.026. No abstract available.

PMID:
29080610
2.

Pasteurella, Yersinia, and Francisella.

Collins FM.

In: Baron S, editor. Medical Microbiology. 4th edition. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 29.

3.

'Rescue' of mini-genomic constructs and viruses by combinations of morbillivirus N, P and L proteins.

Brown DD, Collins FM, Duprex WP, Baron MD, Barrett T, Rima BK.

J Gen Virol. 2005 Apr;86(Pt 4):1077-81.

PMID:
15784901
4.

The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue.

Hsu T, Hingley-Wilson SM, Chen B, Chen M, Dai AZ, Morin PM, Marks CB, Padiyar J, Goulding C, Gingery M, Eisenberg D, Russell RG, Derrick SC, Collins FM, Morris SL, King CH, Jacobs WR Jr.

Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12420-5. Epub 2003 Oct 13.

5.

Susceptibility of mice deficient in the MHC class II transactivator to infection with Mycobacterium tuberculosis.

Repique CJ, Li A, Brickey WJ, Ting JP, Collins FM, Morris SL.

Scand J Immunol. 2003 Jul;58(1):15-22.

6.

Vaccine efficacy of a lysine auxotroph of Mycobacterium tuberculosis.

Pavelka MS Jr, Chen B, Kelley CL, Collins FM, Jacobs WR Jr.

Infect Immun. 2003 Jul;71(7):4190-2.

7.

Current treatment approaches to type 2 diabetes mellitus: successes and shortcomings.

Collins FM.

Am J Manag Care. 2002 Oct;8(16 Suppl):S460-71. Review.

8.

A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis.

Sambandamurthy VK, Wang X, Chen B, Russell RG, Derrick S, Collins FM, Morris SL, Jacobs WR Jr.

Nat Med. 2002 Oct;8(10):1171-4. Epub 2002 Sep 9.

PMID:
12219086
12.

Establishment of a rescue system for canine distemper virus.

Gassen U, Collins FM, Duprex WP, Rima BK.

J Virol. 2000 Nov;74(22):10737-44.

13.
14.
15.
16.

Propelling novel vaccines directed against tuberculosis through the regulatory process.

Brennan MJ, Collins FM, Morris SL.

Tuber Lung Dis. 1999;79(3):145-51. Review.

PMID:
10656113
17.

An aerosol challenge mouse model for Moraxella catarrhalis.

Hu WG, Chen J, Collins FM, Gu XX.

Vaccine. 1999 Dec 10;18(9-10):799-804.

PMID:
10580192
18.

Mycobacterial pathogenesis: a historical perspective.

Collins FM.

Front Biosci. 1998 Jul 23;3:e123-32.

PMID:
9669994
19.

Tuberculosis research in a cold climate.

Collins FM.

Tuber Lung Dis. 1997;78(2):99-107. No abstract available.

PMID:
9692178
20.

Pathogenesis of experimental tuberculosis in animal models.

McMurray DN, Collins FM, Dannenberg AM Jr, Smith DW.

Curr Top Microbiol Immunol. 1996;215:157-79. Review. No abstract available.

PMID:
8791713
21.

Cerebrovascular consequences of repeated exposure to NG-nitro-L-arginine methyl ester.

Kelly PA, Ritchie IM, Collins FM.

Br J Pharmacol. 1995 Nov;116(6):2771-7.

22.

The immune response to mycobacterial infection: development of new vaccines.

Collins FM.

Vet Microbiol. 1994 May;40(1-2):95-110. Review.

PMID:
8073630
23.

Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence.

Pascopella L, Collins FM, Martin JM, Lee MH, Hatfull GF, Stover CK, Bloom BR, Jacobs WR Jr.

Infect Immun. 1994 Apr;62(4):1313-9.

24.

Differential release of tumor necrosis factor-alpha from murine peritoneal macrophages stimulated with virulent and avirulent species of mycobacteria.

Falcone V, Bassey EB, Toniolo A, Conaldi PG, Collins FM.

FEMS Immunol Med Microbiol. 1994 Mar;8(3):225-32.

PMID:
8004059
25.

Identification of a genomic fragment of Mycobacterium tuberculosis responsible for in vivo growth advantage.

Pascopella L, Collins FM, Martin JM, Jacobs WR Jr, Bloom BR.

Infect Agents Dis. 1993 Aug;2(4):282-4.

PMID:
8173811
26.

Tuberculosis: the return of an old enemy.

Collins FM.

Crit Rev Microbiol. 1993;19(1):1-16. Review.

PMID:
8481210
27.

Mycobacteria as cofactors in AIDS.

Collins FM.

Res Microbiol. 1992 May;143(4):369-72. Review. No abstract available.

PMID:
1455062
28.

Immunization of mice with the antigen A60 of Mycobacterium bovis BCG.

Hubbard RD, Flory CM, Collins FM, Cocito C.

Clin Exp Immunol. 1992 Apr;88(1):129-31.

29.

Effects of in vivo T lymphocyte subset depletion on mycobacterial infections in mice.

Flory CM, Hubbard RD, Collins FM.

J Leukoc Biol. 1992 Mar;51(3):225-9.

PMID:
1347311
30.

Immunization of mice with mycobacterial culture filtrate proteins.

Hubbard RD, Flory CM, Collins FM.

Clin Exp Immunol. 1992 Jan;87(1):94-8.

31.

T-cell immune responses in Mycobacterium avium-infected mice.

Hubbard RD, Flory CM, Collins FM.

Infect Immun. 1992 Jan;60(1):150-3.

32.

Antituberculous immunity: new solutions to an old problem.

Collins FM.

Rev Infect Dis. 1991 Sep-Oct;13(5):940-50. Review.

PMID:
1962110
33.
34.

Immunomodulation of mouse macrophage killing of Mycobacterium avium in vitro.

Hubbard RD, Collins FM.

Infect Immun. 1991 Feb;59(2):570-4.

36.
37.

In vivo vs. in vitro killing of virulent Mycobacterium tuberculosis.

Collins FM.

Res Microbiol. 1990 Feb;141(2):212-7; discussion 265-6. No abstract available.

PMID:
2111922
38.
39.
41.
42.

AIDS-related mycobacterial disease.

Collins FM.

Springer Semin Immunopathol. 1988;10(4):375-91. Review. No abstract available.

PMID:
3065953
43.
44.

Mycobacterium avium-complex infections in normal and immunodeficient mice.

Collins FM, Stokes RW.

Tubercle. 1987 Jun;68(2):127-36.

PMID:
2958962
45.
46.
47.

Genetic control of natural resistance to nontuberculous mycobacterial infections in mice.

Orme IM, Stokes RW, Collins FM.

Infect Immun. 1986 Oct;54(1):56-62.

48.
49.

Mycobacterium avium-complex infections and development of the acquired immunodeficiency syndrome: casual opportunist or causal cofactor?

Collins FM.

Int J Lepr Other Mycobact Dis. 1986 Sep;54(3):458-74. Review. No abstract available.

PMID:
2943845
50.

Supplemental Content

Loading ...
Support Center